A critical breakthrough in cancer investigation is emerging with the use of VHH fragments to reactivate mutated p53. This essential cancer protector protein is frequently inactivated in various types of malignancies, https://optimusbookmarks.com/story21886048/nanobodies-restore-p53-the-potential-pathway-for-malignant-treatment